Addus HomeCare Corporation (NASDAQ:ADUS) Given Average Recommendation of "Buy" by Analysts

Key Points

• Addus HomeCare Corporation has received an average recommendation of "Buy" from ten analysts, with one sell rating, seven buy ratings, and two strong buy ratings.
• The company's stock has a current market cap of $2.13 billion and reported a 21.8% increase in revenue year-over-year, with quarterly earnings per share at $1.49, surpassing estimates.
• Insider activity includes significant stock sales, with CEO R Dirk Allison selling 25,000 shares valued at approximately $2.87 million, indicating a 13.06% reduction in his ownership stake.

Addus HomeCare Corporation (NASDAQ:ADUS - Get Free Report) has been assigned an average rating of "Buy" from the ten research firms that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, seven have issued a buy rating and two have issued a strong buy rating on the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $138.8889.

Several equities research analysts have commented on ADUS shares. Macquarie reissued an "outperform" rating and set a $133.00 price target on shares of Addus HomeCare in a research report on Tuesday, June 10th. Royal Bank Of Canada increased their price target on Addus HomeCare from $133.00 to $134.00 and gave the company an "outperform" rating in a research report on Friday, August 22nd. UBS Group initiated coverage on Addus HomeCare in a research report on Tuesday, September 2nd. They set a "buy" rating and a $145.00 price target on the stock. JMP Securities reissued a "market outperform" rating and issued a $150.00 price objective on shares of Addus HomeCare in a report on Wednesday, July 16th. Finally, Stephens reissued an "overweight" rating and issued a $140.00 target price on shares of Addus HomeCare in a research note on Wednesday, September 3rd.

Addus HomeCare Trading Down 0.4%

NASDAQ:ADUS opened at $115.45 on Friday. The company has a market cap of $2.13 billion, a P/E ratio of 25.49, a price-to-earnings-growth ratio of 1.76 and a beta of 0.86. Addus HomeCare has a twelve month low of $88.96 and a twelve month high of $136.72. The business has a 50 day moving average price of $113.01 and a two-hundred day moving average price of $109.00. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.17.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The company reported $1.49 EPS for the quarter, topping analysts' consensus estimates of $1.45 by $0.04. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. The business had revenue of $349.44 million for the quarter, compared to analyst estimates of $345.71 million. During the same quarter in the previous year, the firm posted $1.35 earnings per share. The firm's revenue for the quarter was up 21.8% on a year-over-year basis. As a group, analysts expect that Addus HomeCare will post 4.59 EPS for the current fiscal year.

Insider Activity

In related news, CEO R Dirk Allison sold 25,000 shares of Addus HomeCare stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $114.95, for a total transaction of $2,873,750.00. Following the completion of the transaction, the chief executive officer owned 166,461 shares in the company, valued at approximately $19,134,691.95. This trade represents a 13.06% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Veronica Hill-Milbourne sold 1,571 shares of the firm's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $114.93, for a total value of $180,555.03. Following the completion of the sale, the director directly owned 5,067 shares of the company's stock, valued at approximately $582,350.31. The trade was a 23.67% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 34,310 shares of company stock valued at $3,958,375 in the last quarter. Company insiders own 4.50% of the company's stock.

Institutional Investors Weigh In On Addus HomeCare

A number of large investors have recently added to or reduced their stakes in the business. Ameritas Investment Partners Inc. increased its stake in shares of Addus HomeCare by 5.0% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 1,854 shares of the company's stock valued at $214,000 after acquiring an additional 89 shares in the last quarter. First Hawaiian Bank increased its stake in Addus HomeCare by 2.0% in the first quarter. First Hawaiian Bank now owns 4,898 shares of the company's stock valued at $484,000 after purchasing an additional 95 shares in the last quarter. Maryland State Retirement & Pension System raised its holdings in shares of Addus HomeCare by 1.9% during the second quarter. Maryland State Retirement & Pension System now owns 5,335 shares of the company's stock valued at $615,000 after purchasing an additional 101 shares during the period. GAMMA Investing LLC boosted its position in shares of Addus HomeCare by 6.3% during the 3rd quarter. GAMMA Investing LLC now owns 1,778 shares of the company's stock worth $210,000 after purchasing an additional 105 shares in the last quarter. Finally, CANADA LIFE ASSURANCE Co grew its stake in shares of Addus HomeCare by 0.6% in the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 18,684 shares of the company's stock valued at $2,150,000 after buying an additional 106 shares during the period. Institutional investors own 95.35% of the company's stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.